Literature DB >> 21979834

Behavioral sensitization to 3,4-methylenedioxymethamphetamine is long-lasting and modulated by the context of drug administration.

Kevin T Ball1, Jessalyn E Klein, Jacob A Plocinski, Rachel Slack.   

Abstract

To begin to characterize the temporal profile of behavioral sensitization to the amphetamine derivative 3,4-methylenedioxymethamphetamine (MDMA), rats were treated with either saline or MDMA (5.0 mg/kg) twice daily for 5 days, followed by a challenge injection of MDMA (2.5 mg/kg) either 15 or 100 days later. Because we found previously that contextual drug associations are important for the expression of behavioral sensitization to MDMA following relatively short withdrawal periods, rats received the repeated injections either in their home cages (unpaired group) or in the activity monitors that were used for testing sensitization on challenge day (paired group). Locomotor sensitization was evident at 15 days of withdrawal but only in the paired MDMA-treated group. Interestingly, however, sensitization was apparent at 100 days of withdrawal in both paired and unpaired rats but the form of sensitization differed between groups. Thus, sensitization in paired rats was expressed as an increase in stereotypy, whereas sensitization in unpaired rats was expressed as an increase in locomotion, paralleling locomotion levels in paired animals at 15 days of withdrawal. These results suggest that the neural changes that underlie behavioral sensitization to MDMA are quite enduring but involve an interaction between withdrawal time and the context of drug administration.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21979834      PMCID: PMC3212638          DOI: 10.1097/FBP.0b013e32834d13b4

Source DB:  PubMed          Journal:  Behav Pharmacol        ISSN: 0955-8810            Impact factor:   2.293


  16 in total

1.  Pharmacological studies of the acute and chronic effects of (+)-3, 4-methylenedioxymethamphetamine on locomotor activity: role of 5-hydroxytryptamine(1A) and 5-hydroxytryptamine(1B/1D) receptors.

Authors:  A C McCreary; M G Bankson; K A Cunningham
Journal:  J Pharmacol Exp Ther       Date:  1999-09       Impact factor: 4.030

2.  Acute and subchronic effects of methylenedioxymethamphetamine [(+/-)MDMA] on locomotion and serotonin syndrome behavior in the rat.

Authors:  L J Spanos; B K Yamamoto
Journal:  Pharmacol Biochem Behav       Date:  1989-04       Impact factor: 3.533

3.  Long-term administration of d-amphetamine: progressive augmentation of motor activity and stereotypy.

Authors:  D S Segal; A J Mandell
Journal:  Pharmacol Biochem Behav       Date:  1974 Mar-Apr       Impact factor: 3.533

4.  Context-dependent behavioural and neuronal sensitization in striatum to MDMA (ecstasy) administration in rats.

Authors:  Kevin T Ball; Daniel Budreau; George V Rebec
Journal:  Eur J Neurosci       Date:  2006-07       Impact factor: 3.386

5.  Time course of transient behavioral depression and persistent behavioral sensitization in relation to regional brain monoamine concentrations during amphetamine withdrawal in rats.

Authors:  P E Paulson; D M Camp; T E Robinson
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

6.  Sensitizing regimens of (+/-)3, 4-methylenedioxymethamphetamine (ecstasy) elicit enduring and differential structural alterations in the brain motive circuit of the rat.

Authors:  K T Ball; C L Wellman; E Fortenberry; G V Rebec
Journal:  Neuroscience       Date:  2009-02-21       Impact factor: 3.590

7.  Time course of the development of the enhanced behavioral and biochemical responses to amphetamine after pretreatment with amphetamine.

Authors:  M G Kolta; P Shreve; V De Souza; N J Uretsky
Journal:  Neuropharmacology       Date:  1985-09       Impact factor: 5.250

8.  Studies on the role of dopamine D1 receptors in the development and expression of MDMA-induced behavioral sensitization in rats.

Authors:  María Ramos; Beatriz Goñi-Allo; Norberto Aguirre
Journal:  Psychopharmacology (Berl)       Date:  2004-08-27       Impact factor: 4.530

9.  Critical issues in assessing the behavioral effects of amphetamine.

Authors:  G V Rebec; T R Bashore
Journal:  Neurosci Biobehav Rev       Date:  1984       Impact factor: 8.989

10.  Two dissociable components of behavioral sensitization following repeated amphetamine administration.

Authors:  N J Leith; R Kuczenski
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

View more
  9 in total

1.  Locomotor effects of 3,4-methylenedioxymethamphetamine (MDMA) and its deuterated form in mice: psychostimulant effects, stereotypy, and sensitization.

Authors:  Michael D Berquist; Sebastian Leth-Petersen; Jesper Langgaard Kristensen; William E Fantegrossi
Journal:  Psychopharmacology (Berl)       Date:  2019-11-15       Impact factor: 4.530

2.  Differential involvement of prelimbic and infralimbic medial prefrontal cortex in discrete cue-induced reinstatement of 3,4-methylenedioxymethamphetamine (MDMA; ecstasy) seeking in rats.

Authors:  Kevin T Ball; Mylissa Slane
Journal:  Psychopharmacology (Berl)       Date:  2012-06-19       Impact factor: 4.530

3.  Huperzine A inhibits immediate addictive behavior but not behavioral sensitization following repeated morphine administration in rats.

Authors:  Jinling Sun; Lin Tian; Ruisi Cui; Xinwang Li
Journal:  Exp Ther Med       Date:  2017-02-02       Impact factor: 2.447

4.  Mephedrone ('bath salt') elicits conditioned place preference and dopamine-sensitive motor activation.

Authors:  Renata Lisek; Wei Xu; Ekaterina Yuvasheva; Yi-Ting Chiu; Allen B Reitz; Lee-Yuan Liu-Chen; Scott M Rawls
Journal:  Drug Alcohol Depend       Date:  2012-05-29       Impact factor: 4.492

5.  Mephedrone (4-methylmethcathinone), a principal constituent of psychoactive bath salts, produces behavioral sensitization in rats.

Authors:  Ryan A Gregg; Christopher S Tallarida; Allen Reitz; Christopher McCurdy; Scott M Rawls
Journal:  Drug Alcohol Depend       Date:  2013-07-23       Impact factor: 4.492

6.  Repeated exposure to MDMA and amphetamine: sensitization, cross-sensitization, and response to dopamine D₁- and D₂-like agonists.

Authors:  Sarah Bradbury; David Gittings; Susan Schenk
Journal:  Psychopharmacology (Berl)       Date:  2012-05-05       Impact factor: 4.530

7.  Nicotine-, tobacco particulate matter- and methamphetamine-produced locomotor sensitisation in rats.

Authors:  Katharine A Brennan; Fraser Putt; Penelope Truman
Journal:  Psychopharmacology (Berl)       Date:  2013-03-22       Impact factor: 4.530

8.  Mephedrone in adolescent rats: residual memory impairment and acute but not lasting 5-HT depletion.

Authors:  Craig P Motbey; Emily Karanges; Kong M Li; Shane Wilkinson; Adam R Winstock; John Ramsay; Callum Hicks; Michael D Kendig; Naomi Wyatt; Paul D Callaghan; Iain S McGregor
Journal:  PLoS One       Date:  2012-09-18       Impact factor: 3.240

9.  A Systematic Review of the MDMA Model to Address Social Impairment in Autism.

Authors:  Devahuti Chaliha; John C Mamo; Matthew Albrecht; Virginie Lam; Ryu Takechi; Mauro Vaccarezza
Journal:  Curr Neuropharmacol       Date:  2021       Impact factor: 7.363

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.